Correlation Between Unicycive Therapeutics and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Innate Pharma, you can compare the effects of market volatilities on Unicycive Therapeutics and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Innate Pharma.
Diversification Opportunities for Unicycive Therapeutics and Innate Pharma
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Unicycive and Innate is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Innate Pharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Innate Pharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Innate Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Unicycive Therapeutics is 1.52 times less risky than Innate Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Innate Pharma is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 180.00 in Innate Pharma on November 28, 2024 and sell it today you would earn a total of 40.00 from holding Innate Pharma or generate 22.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Innate Pharma
Performance |
| Timeline |
| Unicycive Therapeutics |
| Innate Pharma |
Unicycive Therapeutics and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Innate Pharma
The main advantage of trading using opposite Unicycive Therapeutics and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals | Innate Pharma vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |